,sid,label,ntype
0,137u,"1,3,7-trimethyluric acid (137U)",substance
1,13cco2,13C-carbon dioxide,substance
2,13cmet,13C-methacetin,substance
3,13u,"1,3-dimethyluric acid (13U)",substance
4,14c-aminopyrine,[14C] aminopyrine,substance
5,14cco2,14C carbon dioxide,substance
6,14c-glycocholic-acid,[14C]glycocholic acid,substance
7,14c-n-methyl-erythromycin,[14C N-methyl] erythromycin,substance
8,14-dihydroxymidazolam,"1,4-dihydroxymidazolam",substance
9,14-hydroxyclarithromycin,14-hydroxyclarithromycin,substance
10,15n3-midazolam,15N3-midazolam,substance
11,17u,"1,7-dimethyluric acid (17U)",substance
12,17u-over-17u-plus-px-plus-1x-plus-1u-plus-afmu,17U/(17U+px+1X+1U+AFMU),substance
13,17u-over-px,17U/px,substance
14,17u-plus-px-over-caf,(17U+px)/caf,substance
15,1-hydroxymidazolam,1-hydroxymidazolam,substance
16,1-hydroxymidazolam-glucuronide,1-hydroxymidazolam glucuronide,substance
17,1-hydroxymidazolam-over-midazolam,1-hydroxymidazolam/midazolam,substance
18,1-methyl-14c-caf,1_methyl_14c_caffeine,substance
19,1r-2r-alpha-hydroxymetoprolol,"(1R,2R)-alpha-hydroxymetoprolol",substance
20,1r-2r-alpha-hydroxymetoprolol-over-r-metoprolol,"(1R,2R)-alpha-hydroxymetoprolol/(R)-metoprolol",substance
21,1r-2s-alpha-hydroxymetoprolol,"(1R,2S)-alpha-hydroxymetoprolol",substance
22,1r-2s-alpha-hydroxymetoprolol-over-s-metoprolol,"(1R,2S)-alpha-hydroxymetoprolol/(S)-metoprolol",substance
23,1s-2r-alpha-hydroxymetoprolol,"(1S,2R)-alpha-hydroxymetoprolol",substance
24,1s-2r-alpha-hydroxymetoprolol-over-r-metoprolol,"(1S,2R)-alpha-hydroxymetoprolol/(R)-metoprolol",substance
25,1s-2s-alpha-hydroxymetoprolol,"(1S,2S)-alpha-hydroxymetoprolol",substance
26,1s-2s-alpha-hydroxymetoprolol-over-s-metoprolol,"(1S,2S)-alpha-hydroxymetoprolol/(S)-metoprolol",substance
27,1-salicylate-glucuronide,1-salicylate glucuronide,substance
28,1u,1-methyluric acid (1U),substance
29,1u-over-1u-plus-1x,1U/(1U+1X),substance
30,1u-over-1x,1U/1X,substance
31,1u-over-3x-plus-7x,1U/(3X+7X),substance
32,1x,1-methylxanthine (1X),substance
33,1x-over-37u,1X/37U,substance
34,1x-over-caf,1X/caffeine,substance
35,1x-over-px,1X/paraxanthine,substance
36,1x-over-tp,1X/theophylline,substance
37,2-14c-caf,2_14c_caffeine,substance
38,2-3h-glucose,[2-3H]glucose,substance
39,2hspar,2-dehydrosparteine,substance
40,2hspar-plus-5hspar,2hspar+5hspar,substance
41,2-hydroxyatorvastatin-acid,2-hydroxyatorvastatin acid,substance
42,2-hydroxyatorvastatin-lactone,2-hydroxyatorvastatin lactone,substance
43,37u,"3,7-dimethyluric acid (37U)",substance
44,3-omg-glucose,[3-OMG]glucose,substance
45,3u,3-methyluric acid (3U),substance
46,3x,3-methylxanthine (3X),substance
47,4hdeb,4-hydroxydebrisoquine,substance
48,4-hydroxyatorvastatin-acid,4-hydroxyatorvastatin acid,substance
49,4-hydroxyatorvastatin-lactone,4-hydroxyatorvastatin lactone,substance
50,4-hydroxyflurbiprofen,4-hydroxyflurbiprofen,substance
51,4-hydroxymidazolam,4-hydroxymidazolam,substance
52,4-hydroxymidazolam-glucuronide,4-hydroxymidazolam glucuronide,substance
53,4-hydroxytolbutamide,4-hydroxytolbutamide,substance
54,5home-over-ome,5-hydroxyomeprazole/omeprazole,substance
55,5hspar,5-dehydrosparteine,substance
56,5-hydroxyomeprazole,5-hydroxyomeprazole,substance
57,5-meo-dalt,5-MeO-DALT,substance
58,5-o-desmethylomeprazole,5‐O‐desmethylomeprazole,substance
59,6-3h-glucose,[6-3H]glucose,substance
60,6beta-hydroxycortisol,6beta-hydroxycortisol,substance
61,6beta-hydroxycortisol-over-cortisol,6beta-hydroxycortisol/cortisol,substance
62,6-hydroxychlorzoxazone,6-hydroxychlorzoxazone,substance
63,6-hydroxychlorzoxazone-over-chlorzoxazone,6-hydroxychlorzoxazone/chlorzoxazone,substance
64,7u,7-methyluric acid (7U),substance
65,7x,7-methylxanthine (7X),substance
66,a1u,6-Amino-5-(formyl-N-methylamino)-1-methyluracil (A1U),substance
67,a3u,6-Amino-5-(formyl-N-methylamino)-1-methyluracil (A3U),substance
68,aamu,5-Acetylamino-6-amino-3-methyluracil (AAMU),substance
69,aamu-over-aamu-plus-1u-plus-1x,AAMU/(AAMU+1U+1X),substance
70,aamu-plus-1u-plus-1x-over-17u,(AAMU+1U+1X)/17U,substance
71,abcb11-genotype,ABCB11 genotype,measurement_type
72,abcb11-genotype-not-reported,Not reported ABCB11 genotype,choice
73,abcb1c3435t-c-over-c,ABCB1 C3435T C/C,choice
74,abcb1c3435t-t-over-c,ABCB1 C3435T T/C,choice
75,abcb1c3435t-t-over-t,ABCB1 C3435T T/T,choice
76,abcb1cgc,ABCB1 CGC,choice
77,abcb1g2677t-over-a-a-over-a,ABCB1 G2677T/A A/A,choice
78,abcb1g2677t-over-a-g-over-a,ABCB1 G2677T/A G/A,choice
79,abcb1g2677t-over-a-g-over-g,ABCB1 G2677T/A G/G,choice
80,abcb1g2677t-over-a-g-over-t,ABCB1 G2677T/A G/T,choice
81,abcb1g2677t-over-a-t-over-a,ABCB1 G2677T/A T/A,choice
82,abcb1g2677t-over-a-t-over-t,ABCB1 G2677T/A T/T,choice
83,abcb1-genotype,ABCB1 genotype,measurement_type
84,abcb1-genotype-not-reported,Not reported ABCB1 genotype,choice
85,abcb1non-ttt,ABCB1 Non-TTT,choice
86,abcb1t1236c-c-over-c,ABCB1 T1236C C/C,choice
87,abcb1t1236c-t-over-c,ABCB1 T1236C T/C,choice
88,abcb1t1236c-t-over-t,ABCB1 T1236C T/T,choice
89,abcb1ttt,ABCB1 TTT,choice
90,abcc2-c1446g-c-over-c,ABCC2 C1446G C/C,choice
91,abcc2-c1446g-c-over-g,ABCC2 C1446G C/G,choice
92,abcc2-c1446g-g-over-g,ABCC2 C1446G G/G,choice
93,abcc2-g1249a-a-over-a,ABCC2 G1249A A/A,choice
94,abcc2-g1249a-g-over-a,ABCC2 G1249A G/A,choice
95,abcc2-g1249a-g-over-g,ABCC2 G1249A G/G,choice
96,abcc2-g4544a-a-over-a,ABCC2 G4544A A/A,choice
97,abcc2-g4544a-g-over-a,ABCC2 G4544A G/A,choice
98,abcc2-g4544a-g-over-g,ABCC2 G4544A G/G,choice
99,abcc2-genotype,ABCC2 genotype,measurement_type
100,abcc2-genotype-not-reported,Not reported ABCC2 genotype,choice
101,abcc2-rs717620-c-over-c,ABCC2 rs717620 C/C,choice
102,abcc2-rs717620-c-over-t,ABCC2 rs717620 C/T,choice
103,abcc2-rs717620-t-over-t,ABCC2 rs717620 T/T,choice
104,abcc2-t3563a-a-over-a,ABCC2 T3563A A/A,choice
105,abcc2-t3563a-t-over-a,ABCC2 T3563A T/A,choice
106,abcc2-t3563a-t-over-t,ABCC2 T3563A T/T,choice
107,abcg2-c-34-a-over-g,ABCG2 c.34 A/G,choice
108,abcg2-c-34-g-over-g,ABCG2 c.34 G/G,choice
109,abcg2-c-421-a-over-a,ABCG2 c.421 A/A,choice
110,abcg2-c-421-c-over-a,ABCG2 c.421 C/A,choice
111,abcg2-c-421-c-over-c,ABCG2 c.421 C/C,choice
112,abcg2-genotype,ABCG2 genotype,measurement_type
113,abcg2-genotype-not-reported,Not reported ABCG2 genotype,choice
114,abstinence,abstinence,measurement_type
115,abstinence-alcohol,abstinence alcohol,measurement_type
116,abstinence-marijuana,abstinence marijuana,measurement_type
117,abstinence-medication,abstinence medication,measurement_type
118,abstinence-oral-contraceptives,abstinence oral contraceptives,measurement_type
119,abstinence-smoking,abstinence smoking,measurement_type
120,abstinence-substances-all,substances all,info_node
121,abt,Aminopyrine breath test (ABT),measurement_type
122,acetylcysteine,acetylcysteine,substance
123,acetylsalicylic-acid,acetylsalicylic acid,substance
124,acid,acid,substance
125,active-atorva-inhibitors,Active HMG-CoA 	reductase inhibitors (atorvastatin),substance
126,active-lova-inhibitors,Active HMG-CoA reductase inhibitors (lovastatin),substance
127,active-pra-inhibitors,Active HMG-CoA reductase inhibitors (pravastatin),substance
128,active-simva-inhibitors,Active HMG-CoA reductase inhibitors (simvastatin),substance
129,acute-glomerulonephritis,acute glomerulonephritis,choice
130,adipose,adipose tissue,tissue
131,administration-form,administration form,form
132,administration-method,administration method,application
133,administration-route,administration route,route
134,admu,ADMU,substance
135,adolescent,adolescent,choice
136,adult,adult,choice
137,afmu,5-Acetylamino-6-formylamino-3-methyluracil (AFMU),substance
138,afmu-over-1x,AFMU/1X,substance
139,afmu-over-afmu-plus-1u-plus-1x,AFMU/(AFMU+1U+1X),substance
140,afmu-plus-1u-plus-1x,AFMU+1U+1X,substance
141,afmu-plus-1u-plus-1x-over-17u,(AFMU+1U+1X)/17U,substance
142,afmu-plus-1u-plus-1x-plus-17u,AFMU+1U+1X+17U,substance
143,afmu-plus-1u-plus-1x-plus-17u-plus-px-over-caf,(AFMU+1U+1X+17U+px)/caf,substance
144,african,African,choice
145,african-american,African American,choice
146,afro-trinidadians,Afro–Trinidadians,choice
147,age,age,measurement_type
148,age-categorial,age (categorial),measurement_type
149,age-categorial-not-reported,Not reported age (categorial),choice
150,albumin,albumin,substance
151,albumin-measurement,albumin measurement,measurement_type
152,alcohol,alcohol,measurement_type
153,alcohol-amount,alcohol amount,measurement_type
154,alcohol-duration,alcohol duration,measurement_type
155,alcoholic-hepatitis,alcoholic-hepatitis,choice
156,alcoholic-liver-cirrhosis,alcoholic liver cirrhosis,choice
157,alcoholic-liver-disease,alcoholic liver disease,choice
158,alcohol-no,No alcohol,choice
159,alcohol-not-reported,Not reported alcohol,choice
160,alcohol-status,alcohol status,measurement_type
161,alcohol-yes,alcohol,choice
162,alfentanil,alfentanil,substance
163,all-14c-caffeine-equivalents,all_14c_caffeine_equivalents,substance
164,allopurinol,allopurinol,substance
165,alp,Alkaline phosphatase (ALP),substance
166,alpha-hydroxymetoprolol,alpha-hydroxymetoprolol,substance
167,alprazolam,alprazolam,substance
168,alt,Alanine aminotransferase (ALT),substance
169,aluminium-hydroxide,aluminium hydroxide,substance
170,ambulant,ambulant,choice
171,american-indian,American Indian,choice
172,amikacin,amikacin,substance
173,amiloride,amiloride,substance
174,aminopyrine,aminopyrine,substance
175,amlodipine,amlodipine,substance
176,amount,amount,measurement_type
177,amount-substances-all,substances all,info_node
178,amphetamine,amphetamine,substance
179,analgesics,analgesics,substance
180,anephric,anephric,choice
181,anthropometric-measurement,anthropometric measurement,measurement_type
182,anticonvulsants,anticonvulsants,substance
183,antipyrine,antipyrine,substance
184,apap,paracetamol,substance
185,apapcys,paracetamol cysteine,substance
186,apapcys-plus-apapglu,apapcys+apapglu,substance
187,apapcys-plus-apapmer,apapcys+apapmer,substance
188,apapglu,paracetamol glucuronide,substance
189,apapgsh,paracetamol glutathione,substance
190,apapmer,paracetamol mercapturate,substance
191,apap-plus-apapsul-plus-apapglu-plus-apapcys-plus-apapmer,apap+apapsul+apapglu+apapcys+apapmer,substance
192,apap-plus-apapsul-plus-apapglu-plus-apapcys-plus-apapmer-plus-apapgsh,apap+apapsul+apapglu+apapcys+apapmer+apapgsh,substance
193,apap-plus-apapsul-plus-apapglu-plus-apapgsh,apap+apapsul+apapglu+apapgsh,substance
194,apapsul,paracetamol sulfate,substance
195,apapsul-plus-apapglu,apapsul+apapglu,substance
196,apolipoprotein-a-i,apoA-I,substance
197,apolipoprotein-a-ii,apoA-II,substance
198,apolipoprotein-a-ii-over-apolipoprotein-a-ii,Lp A-II:A-I,substance
199,apolipoprotein-a-i-over-apolipoprotein-a-ii,Lp A-I:A-II,substance
200,apolipoprotein-b-100,apoB-100,substance
201,apolipoprotein-b100-plus-b48,apoB100+48,substance
202,apolipoprotein-c-ii,apoC-II,substance
203,apolipoprotein-c-iii,apoC-III,substance
204,apolipoprotein-c-iii-over-apolipoprotein-b-100,Lp C-III:B,substance
205,apolipoprotein-e,apoE,substance
206,apolipoprotein-e-over-apolipoprotein-b-100,Lp E:B,substance
207,apolipoprotein-e-over-apolipoprotein-b-100-times-apolipoprotein-b-100-over-apolipoprotein-c-iii,Lp E:B/Lp C-III:B,substance
208,arab-american,Arab American,choice
209,armodafinil,armodafinil,substance
210,artemisinin,artemisinin,substance
211,arterial-blood,arterial blood,tissue
212,arterial-plasma,arterial plasma,tissue
213,ascites,ascites,choice
214,asian,Asian,choice
215,asian-indian,Asian Indian,choice
216,asleep,asleep,choice
217,assay,assay,method
218,ast,Aspartate aminotransferase (AST),substance
219,asthma,asthma,choice
220,atazanavir,atazanavir,substance
221,atenolol,atenolol,substance
222,atorvastatin,atorvastatin,substance
223,atorvastatin-acid,atorvastatin acid,substance
224,atovarstatin-lactone,atorvastatin lactone,substance
225,atropine,atropine,substance
226,auc-end,area under curve (AUC) end,measurement_type
227,auc-end-substances-all,substances all,info_node
228,auc-inf,area under curve (AUC) infinity,measurement_type
229,auc-inf-substances-all,substances all,info_node
230,auc-measurement,AUC measurement,measurement_type
231,auc-per-dose,area under curve (AUC) per dose,measurement_type
232,auc-per-dose-substances-all,substances all,info_node
233,auc-ratio,AUC ratio,measurement_type
234,auc-relative,area under curve (AUC) relative,measurement_type
235,auc-relative-substances-all,substances all,info_node
236,aumc-inf,Area under first moment curve to infinity (AUMC),measurement_type
237,aumc-inf-substances-all,substances all,info_node
238,awake,awake,choice
239,azygos-blood-flow,Azygos blood flow,measurement_type
240,bcaa,Branch-chained amino acids (BCAA),substance
241,beclometasone,beclometasone,substance
242,beta-blocker,beta-blocker,substance
243,bifendate,bifendate,substance
244,bile,bile,substance
245,bile-acids,bile acids,substance
246,bile-duct,bile duct,tissue
247,bile-flow,bile flow,measurement_type
248,bile-fluid,bile,tissue
249,biliary-liver-disease,biliary liver disease,choice
250,biliary-obstruction,biliary obstruction,choice
251,biliary-stasis,biliary stasis,choice
252,bilirubin,bilirubin,substance
253,bilirubin-unconjugated,bilirubin unconjugated,substance
254,bioavailability,bioavailability,measurement_type
255,biochemistry-abnormal,biochemistry abnormal,choice
256,biochemistry-categorial,biochemistry (categorial),measurement_type
257,biochemistry-categorial-not-reported,Not reported biochemistry (categorial),choice
258,biochemistry-decreased,biochemistry decreased,choice
259,biochemistry-elevated,biochemistry elevated,choice
260,biochemistry-level,biochemistry level,measurement_type
261,biochemistry-normal,biochemistry normal,choice
262,black,Black,choice
263,black-cohosh-root-extract,black cohosh root extract,substance
264,blood,blood,tissue
265,blood-cell-count-categorial,blood cell count (categorial),measurement_type
266,blood-cell-count-categorial-not-reported,Not reported blood cell count (categorial),choice
267,blood-cell-measurement,blood cell measurement,measurement_type
268,blood-flow,blood flow,measurement_type
269,blood-index,blood index,measurement_type
270,blood-measurement,blood measurement,measurement_type
271,blood-pressure,blood pressure,measurement_type
272,blood-pressure-categorical,blood pressure (categorical),measurement_type
273,blood-pressure-categorical-not-reported,Not reported blood pressure (categorical),choice
274,blood-pressure-diastolic,blood pressure diastolic,measurement_type
275,blood-pressure-elevated,elevated,choice
276,blood-pressure-normal,normal,choice
277,blood-pressure-systolic,blood pressure systolic,measurement_type
278,bmi,body mass index (BMI),measurement_type
279,body-fat-percentage,body fat percentage,measurement_type
280,body-position,body position,measurement_type
281,body-position-not-reported,Not reported body position,choice
282,body-surface-area,body surface area (BSA),measurement_type
283,body-temperature,body temperature,measurement_type
284,bos-taurus,Bos taurus,choice
285,bp-ratio,blood/plasma ratio (BP),measurement_type
286,breastfeeding,breastfeeding,measurement_type
287,breastfeeding-no,No breastfeeding,choice
288,breastfeeding-not-reported,Not reported breastfeeding,choice
289,breastfeeding-yes,breastfeeding,choice
290,breath,breath,tissue
291,breath-test,breath test,measurement_type
292,breath-test-not-reported,Not reported breath test,choice
293,bromazepam,bromazepam,substance
294,brussel-sprouts,brussel sprouts,substance
295,bsp,bromsulpthalein,substance
296,buccal,buccal,route
297,bupropion,bupropion,substance
298,buspirone,buspirone,substance
299,butylscopolamine,butylscopolamine,substance
300,c6g,codeine-6-glucuronide,substance
301,c6g-plus-cod-plus-mor-plus-ncod,c6g+cod+mor+ncod,substance
302,cabbage,cabbage,substance
303,caf,caffeine (137X),substance
304,caffeine-citrate,caffeine citrate,substance
305,caffeine-monohydrate,caffeine monohydrate,substance
306,caf-over-px,caffeine/paraxanthine,substance
307,caf-plus-px,caffeine+paraxanthine,substance
308,calcium,calcium,substance
309,calculation,calculation,calculation_type
310,campesterol,campesterol,substance
311,cancer,cancer,choice
312,canis-familiaris,Canis familiaris,choice
313,capsaicin,capsaicin,substance
314,capsule,capsule,form
315,carbamazepine,carbamazepine,substance
316,carbon-monoxide,carbon monoxide (CO),substance
317,cardiac-arrhythmia,cardiac arrhythmia,choice
318,cardiac-function-test,cardiac function test,measurement_type
319,cardiac-function-test-not-reported,Not reported cardiac function test,choice
320,cardiac-index,Cardiac index (CI),measurement_type
321,cardiac-output,cardiac output (CO),measurement_type
322,cardiovascular-disease,cardiovascular disease,choice
323,cardiovascular-measurement,cardiovascular measurement,measurement_type
324,caucasian,Caucasian,choice
325,caverage,average concentration,measurement_type
326,cc,column chromatography (CC),method
327,ccm,codeine containing medication,substance
328,cecum,cecum,tissue
329,cell-count-abnormal,cell count abnormal,choice
330,cell-count-decreased,cell count decreased,choice
331,cell-count-elevated,cell count eleveated,choice
332,cell-count-levels,cell count levels,measurement_type
333,cell-count-normal,cell count normal,choice
334,central-sleep-apnea,central sleep apnea,choice
335,cerebrospinal-fluid,cerebrospinal fluid,tissue
336,cf-irms,Continuous-flow isotope ratio mass spectrometry (CFIRMS),method
337,cgc,Capillary gas chromatography,method
338,chemistry-measurement,chemistry measurement,measurement_type
339,chewing-gum,chewing gum,form
340,child,child,choice
341,child-pugh-class-a,Child-Pugh class A,choice
342,child-pugh-class-b,Child-Pugh class B,choice
343,child-pugh-class-c,Child-Pugh class C,choice
344,child-pugh-class-unkown,Child-Pugh class unknown,choice
345,child-pugh-score,Child-Pugh score,measurement_type
346,child-pugh-score-not-reported,Not reported child-pugh score,choice
347,child-pugh-score-numeric,Child-Pugh score (numeric),measurement_type
348,chinese,Chinese,choice
349,chlordiazepoxide,chlordiazepoxide,substance
350,chloride,chloride,substance
351,chloroquine,chloroquine,substance
352,chlorzoxazone,chlorzoxazone,substance
353,chocolate,chocolate,substance
354,cholecystectomy,cholecystectomy,choice
355,cholesterol,cholesterol,substance
356,cholestyramine,Cholestyramine,substance
357,chromatography,chromatography,method
358,chronic-bronchitis,chronic bronchitis,choice
359,chronic-glomerulonephritis,chronic glomerulonephritis,choice
360,chronic-hepatitis,chronic hepatitis,choice
361,chronic-myelogenous-leukemia,chronic myelogenous leukemia,choice
362,chronic-pancreatitis,chronic pancreatitis,choice
363,chronic-pyelonephritis,chronic pyelonephritis,choice
364,cilostazol,cilostazol,substance
365,cimetidine,cimetidine,substance
366,cinacalcet,cinacalcet,substance
367,cinacalcet-hydrochloride,cinacalcet hydrochloride,substance
368,ciprofloxacin,ciprofloxacin,substance
369,circadian-status,circadian status (time of day),measurement_type
370,circadian-status-not-reported,Not reported circadian status (time of day),choice
371,cirrhotic-liver-disease,cirrhotic liver disease,measurement_type
372,cisapride,cisapride,substance
373,clamp-infusion,clamp infusion,application
374,clarithromycin,clarithromycin,substance
375,clearance,clearance (Cl),measurement_type
376,clearance-intrinsic,clearance intrinsic,measurement_type
377,clearance-intrinsic-substances-all,substances all,info_node
378,clearance-intrinsic-unbound,clearance intrinsic unbound,measurement_type
379,clearance-intrinsic-unbound-substances-all,substances all,info_node
380,clearance-measurement,clearance measurement,measurement_type
381,clearance-nonrenal,clearance nonrenal,measurement_type
382,clearance-other,clearance other,measurement_type
383,clearance-partial,clearance partial,measurement_type
384,clearance-partial-substances-all,substances all,info_node
385,clearance-renal,clearance renal,measurement_type
386,clearance-renal-substances-all,substances all,info_node
387,clearance-renal-unbound,clearance renal unbound,measurement_type
388,clearance-renal-unbound-substances-all,substances all,info_node
389,clearance-substances-all,substances all,info_node
390,clearance-unbound,clearance unbound,measurement_type
391,clearance-unbound-substances-all,substances all,info_node
392,clonazepam,clonazepam,substance
393,clotrimazole,clotrimazole,substance
394,clozapine,clozapine,substance
395,cmax,maximum concentration (Cmax),measurement_type
396,cmax-substances-all,substances all,info_node
397,cmin,minimal concentration (Cmin),measurement_type
398,co2,carbon dioxide,substance
399,cocaine,cocaine,substance
400,cocoa,cocoa,substance
401,cod,codeine,substance
402,cod-over-c6g,cod/c6g,substance
403,cod-over-mor,codeine/morphine,substance
404,cod-over-mor-plus-m3g-plus-m6g-plus-nmor,cod/(mor+m3g+m6g+nmor),substance
405,cod-over-ncod-plus-ncg-plus-nmor,cod/(ncod+ncg+nmor),substance
406,cod-p,codeine phosphate,substance
407,cod-plus-c6g-plus-ncod,cod+c6g+ncod,substance
408,cod-s,codeine sulfate anhydrous,substance
409,coffee,coffee,substance
410,coke,coke,substance
411,competition-dialysis,competition dialysis,method
412,concentration,concentration,measurement_type
413,concentration-change,concentration change,measurement_type
414,concentration-change-absolute,concentration change absolute,measurement_type
415,concentration-per-dose,concentration per dose,measurement_type
416,concentration-ss,steady-state concentration,measurement_type
417,concentration-ss-per-dose,steady state concentration per dose,measurement_type
418,concentration-substances-all,substances all,info_node
419,concentration-unbound,concentration unbound,measurement_type
420,concentration-unbound-substances-all,substances all,info_node
421,constant-infusion,constant infusion,application
422,consumption,consumption,measurement_type
423,consumption-substances-all,substances all,info_node
424,cortisol,cortisol,substance
425,cotinine,cotinine,substance
426,cpeptide,C-peptide,substance
427,c-reactive-protein,CRP,substance
428,creatine-kinase,creatine kinase,substance
429,creatinine,creatinine,substance
430,cryptogenic-cirrhosis,cryptogenic cirrhosis,choice
431,cthrough,through concentration,measurement_type
432,cumulative-amount,cumulative amount,measurement_type
433,cumulative-amount-substances-all,substances all,info_node
434,cumulative-metabolic-ratio,cumulative metabolic ratio,measurement_type
435,curcumin,curcumin,substance
436,curcuminoids,curcuminoids,substance
437,cyp1a2-163c-a-a-over-a,CYP1A2 -163C>A a/a,choice
438,cyp1a2-163c-a-c-over-a,CYP1A2 -163C>A c/a,choice
439,cyp1a2-163c-a-c-over-c,CYP1A2 -163C>A c/c,choice
440,cyp1a2-genotype,CYP1A2 genotype,measurement_type
441,cyp1a2-genotype-not-reported,Not reported cyp1a2 genotype,choice
442,cyp1a2-phenotype,CYP1A2 phenotype,measurement_type
443,cyp1a2-phenotype-not-reported,Not reported cyp1a2 phenotype,choice
444,cyp1a2-rs2470893-g-a-zero-a-allele,CYP1A2 rs2470893 G>A (zero A allele),choice
445,cyp1a2-rs2470893-one-a-allele,CYP1A2 rs2470893 (one A allele),choice
446,cyp1a2-rs2470893-two-a-allele,CYP1A2 rs2470893 (two A allele),choice
447,cyp1a2-times-1a-over-times-1a,CYP1A2 *1a/*1a,choice
448,cyp1a2-times-1a-over-times-1f,CYP1A2 *1a/*1f,choice
449,cyp1a2-times-1b-times-1b,"CYP1A2 *1B,*1B",choice
450,cyp1a2-times-1b-times-1c-times-1d-times-1f-and-times-1b,"CYP1A2 *1B,*1C,*1D,*1F and *1B",choice
451,cyp1a2-times-1b-times-1c-times-1d-times-1f-and-times-1b-times-1c-times-1d-times-1f,"CYP1A2 *1B,*1C,*1D,*1F and *1B,*1C,*1D,*1F",choice
452,cyp1a2-times-1b-times-1c-times-1d-times-1f-and-times-1b-times-1d-times-1e-times-1f,"CYP1A2 *1B,*1C,*1D,*1F and *1B,*1D,*1E,*1F",choice
453,cyp1a2-times-1b-times-1c-times-1d-times-1f-and-times-1f,"CYP1A2 *1B,*1C,*1D,*1F and *1F",choice
454,cyp1a2-times-1b-times-1d-times-1e-times-1f-and-times-1b,"CYP1A2 *1B,*1D,*1E,*1F and *1B",choice
455,cyp1a2-times-1b-times-1d-times-1e-times-1f-and-times-1b-times-1d-times-1e-times-1f,"CYP1A2 *1B,*1D,*1E,*1F and *1B,*1D,*1E,*1F",choice
456,cyp1a2-times-1b-times-1d-times-1e-times-1f-and-times-1f,"CYP1A2 *1B,*1D,*1E,*1F and *1F",choice
457,cyp1a2-times-1b-times-1d-times-1e-times-1f-and-times-1k,"CYP1A2 *1B,*1D,*1E,*1F and *1K",choice
458,cyp1a2-times-1b-times-1d-times-1f-and-times-1b,"CYP1A2 *1B,*1D,*1F and *1B",choice
459,cyp1a2-times-1b-times-1d-times-1f-and-times-1b-times-1c-times-1d-times-1f,"CYP1A2 *1B,*1D,*1F and *1B,*1C,*1D, *1F",choice
460,cyp1a2-times-1b-times-1d-times-1f-and-times-1b-times-1d-times-1e-times-1f,"CYP1A2 *1B,*1D,*1F and *1B,*1D,*1E, *1F",choice
461,cyp1a2-times-1b-times-1d-times-1f-and-times-1b-times-1d-times-1f,"CYP1A2 *1B,*1D,*1F and *1B,*1D,*1F",choice
462,cyp1a2-times-1b-times-1d-times-1f-and-times-1f,"CYP1A2 *1B,*1D,*1F and *1F",choice
463,cyp1a2-times-1b-times-1d-times-1f-and-times-1f-c-730-t,"CYP1A2 *1B,*1D,*1F and *1F, C(-730)T",choice
464,cyp1a2-times-1b-times-1f,"CYP1A2 *1B,*1F",choice
465,cyp1a2-times-1b-times-1f-and-times-1b,"CYP1A2 *1B,*1F and *1B",choice
466,cyp1a2-times-1b-times-1f-and-times-1f,"CYP1A2 *1B,*1F and *1F",choice
467,cyp1a2-times-1b-times-1f-and-times-6,"CYP1A2 *1B,*1F and *6",choice
468,cyp1a2-times-1c-over-times-1f,CYP1A2 *1c/*1f,choice
469,cyp1a2-times-1c-times-1f-over-times-1c-times-1f,CYP1A2 *1c*1f/*1c*1f,choice
470,cyp1a2-times-1f-over-times-1f,CYP1A2 *1f/*1f,choice
471,cyp1a2-times-1f-times-1f,"CYP1A2 *1F,*1F",choice
472,cyp2c19-genotype,CYP2C19 genotype,measurement_type
473,cyp2c19-genotype-not-reported,Not reported cyp2c19 genotype,choice
474,cyp2c19-phenotype,CYP2C19 phenotype,measurement_type
475,cyp2c19-phenotype-not-reported,Not reported cyp2c19 phenotype,choice
476,cyp2c9-a-over-a,CYP2C9 A/A,choice
477,cyp2c9-c-over-a,CYP2C9 C/A,choice
478,cyp2c9-genotype,CYP2C9 genotype,measurement_type
479,cyp2c9-genotype-not-reported,Not reported cyp2c9 genotype,choice
480,cyp2d6-activity-score,CYP2D6 activity score,measurement_type
481,cyp2d6-genotype,CYP2D6 genotype,measurement_type
482,cyp2d6-genotype-not-reported,Not reported cyp2d6 genotype,choice
483,cyp2d6-phenotype,CYP2D6 phenotype,measurement_type
484,cyp2d6-phenotype-not-reported,Not reported cyp2d6 phenotype,choice
485,cyp2d6-times-10-over-times-10,CYP2D6 *10/*10,choice
486,cyp2d6-times-10-over-times-10x2,CYP2D6 *10/*10x2,choice
487,cyp2d6-times-10-over-times-14,CYP2D6 *10/*14,choice
488,cyp2d6-times-10-over-times-17,CYP2D6 *10/*17,choice
489,cyp2d6-times-10-over-times-36,CYP2D6 *10/*36,choice
490,cyp2d6-times-10-over-times-41,CYP2D6 *10/*41,choice
491,cyp2d6-times-10-over-times-41x2,CYP2D6 *10/*41x2,choice
492,cyp2d6-times-13-plus-times-1-over-times-4,CYP2D6 *13+*1/*4,choice
493,cyp2d6-times-17-over-times-17,CYP2D6 *17/*17,choice
494,cyp2d6-times-17-over-times-29,CYP2D6 *17/*29,choice
495,cyp2d6-times-17-over-times-35,CYP2D6 *17/*35,choice
496,cyp2d6-times-17-over-times-41,CYP2D6 *17/*41,choice
497,cyp2d6-times-17-over-times-42,CYP2D6 *17/*42,choice
498,cyp2d6-times-1-over-times-1,CYP2D6 *1/*1,choice
499,cyp2d6-times-1-over-times-10,CYP2D6 *1/*10,choice
500,cyp2d6-times-1-over-times-10x2,CYP2D6 *1/*10x2,choice
501,cyp2d6-times-1-over-times-17,CYP2D6 *1/*17,choice
502,cyp2d6-times-1-over-times-1x2,CYP2D6 *1/*1x2,choice
503,cyp2d6-times-1-over-times-1xn,CYP2D6 *1/*1xN,choice
504,cyp2d6-times-1-over-times-2,CYP2D6 *1/*2,choice
505,cyp2d6-times-1-over-times-21,CYP2D6 *1/*21,choice
506,cyp2d6-times-1-over-times-29,CYP2D6 *1/*29,choice
507,cyp2d6-times-1-over-times-2x2,CYP2D6 *1/*2x2,choice
508,cyp2d6-times-1-over-times-2xn,CYP2D6 *1/*2xN,choice
509,cyp2d6-times-1-over-times-3,CYP2D6 *1/*3,choice
510,cyp2d6-times-1-over-times-35,CYP2D6 *1/*35,choice
511,cyp2d6-times-1-over-times-36,CYP2D6 *1/*36,choice
512,cyp2d6-times-1-over-times-4,CYP2D6 *1/*4,choice
513,cyp2d6-times-1-over-times-41,CYP2D6 *1/*41,choice
514,cyp2d6-times-1-over-times-42,CYP2D6 *1/*42,choice
515,cyp2d6-times-1-over-times-45-or-46,CYP2D6 *1/*45 or 46,choice
516,cyp2d6-times-1-over-times-4x2,CYP2D6 *1/*4x2,choice
517,cyp2d6-times-1-over-times-5,CYP2D6 *1/*5,choice
518,cyp2d6-times-1-over-times-6,CYP2D6 *1/*6,choice
519,cyp2d6-times-1-over-times-7,CYP2D6 *1/*7,choice
520,cyp2d6-times-1-over-times-9,CYP2D6 *1/*9,choice
521,cyp2d6-times-1x2-over-times-1,CYP2D6 *1x2/*1,choice
522,cyp2d6-times-1x2-over-times-10,CYP2D6 *1x2/*10,choice
523,cyp2d6-times-1x2-over-times-17,CYP2D6 *1x2/*17,choice
524,cyp2d6-times-1x2-over-times-2,CYP2D6 *1x2/*2,choice
525,cyp2d6-times-1x2-over-times-4,CYP2D6 *1x2/*4,choice
526,cyp2d6-times-1x2-over-times-41,CYP2D6 *1x2/*41,choice
527,cyp2d6-times-1x2-over-times-5,CYP2D6 *1x2/*5,choice
528,cyp2d6-times-1xn-over-times-17,CYP2D6 *1xN/*17,choice
529,cyp2d6-times-1xn-over-times-35,CYP2D6 *1xN/*35,choice
530,cyp2d6-times-29-over-times-29,CYP2D6 *29/*29,choice
531,cyp2d6-times-29-over-times-41,CYP2D6 *29/*41,choice
532,cyp2d6-times-29-over-times-45-or-46,CYP2D6 *29/*45 or 46,choice
533,cyp2d6-times-2-over-times-10,CYP2D6 *2/*10,choice
534,cyp2d6-times-2-over-times-14,CYP2D6 *2/*14,choice
535,cyp2d6-times-2-over-times-17,CYP2D6 *2/*17,choice
536,cyp2d6-times-2-over-times-1x2,CYP2D6 *2/*1x2,choice
537,cyp2d6-times-2-over-times-2,CYP2D6 *2/*2,choice
538,cyp2d6-times-2-over-times-21,CYP2D6 *2/*21,choice
539,cyp2d6-times-2-over-times-29,CYP2D6 *2/*29,choice
540,cyp2d6-times-2-over-times-2x2,CYP2D6 *2/*2x2,choice
541,cyp2d6-times-2-over-times-3,CYP2D6 *2/*3,choice
542,cyp2d6-times-2-over-times-36-plus-times-10x2,CYP2D6 *2/*36+*10x2,choice
543,cyp2d6-times-2-over-times-4,CYP2D6 *2/*4,choice
544,cyp2d6-times-2-over-times-41,CYP2D6 *2/*41,choice
545,cyp2d6-times-2-over-times-4x2,CYP2D6 *2/*4x2,choice
546,cyp2d6-times-2-over-times-5,CYP2D6 *2/*5,choice
547,cyp2d6-times-2-over-times-6,CYP2D6 *2/*6,choice
548,cyp2d6-times-2-over-times-9,CYP2D6 *2/*9,choice
549,cyp2d6-times-2x2-over-times-1,CYP2D6 *2x2/*1,choice
550,cyp2d6-times-2x2-over-times-17,CYP2D6 *2x2/*17,choice
551,cyp2d6-times-2x2-over-times-3,CYP2D6 *2x2/*3,choice
552,cyp2d6-times-2x2-over-times-4,CYP2D6 *2x2/*4,choice
553,cyp2d6-times-2x2-over-times-5,CYP2D6 *2x2/*5,choice
554,cyp2d6-times-35-over-times-35,CYP2D6 *35/*35,choice
555,cyp2d6-times-3-over-times-2,CYP2D6 *3/*2,choice
556,cyp2d6-times-3-over-times-2x2,CYP2D6 *3/*2x2,choice
557,cyp2d6-times-3-over-times-3,CYP2D6 *3/*3,choice
558,cyp2d6-times-3-over-times-4,CYP2D6 *3/*4,choice
559,cyp2d6-times-3-over-times-5,CYP2D6 *3/*5,choice
560,cyp2d6-times-41-over-null,CYP2D6 *41/null,choice
561,cyp2d6-times-41-over-times-41,CYP2D6 *41/*41,choice
562,cyp2d6-times-4-over-times-10,CYP2D6 *4/*10,choice
563,cyp2d6-times-4-over-times-17,CYP2D6 *4/*17,choice
564,cyp2d6-times-4-over-times-36,CYP2D6 *4/*36,choice
565,cyp2d6-times-4-over-times-4,CYP2D6 *4/*4,choice
566,cyp2d6-times-4-over-times-41,CYP2D6 *4/*41,choice
567,cyp2d6-times-4-over-times-5,CYP2D6 *4/*5,choice
568,cyp2d6-times-4-over-times-6,CYP2D6 *4/*6,choice
569,cyp2d6-times-4-over-times-9,CYP2D6 *4/*9,choice
570,cyp2d6-times-4x2-over-times-17,CYP2D6 *4x2/*17,choice
571,cyp2d6-times-5-over-times-10,CYP2D6 *5/*10,choice
572,cyp2d6-times-5-over-times-14,CYP2D6 *5/*14,choice
573,cyp2d6-times-5-over-times-16,CYP2D6 *5/*16,choice
574,cyp2d6-times-5-over-times-17,CYP2D6 *5/*17,choice
575,cyp2d6-times-5-over-times-29,CYP2D6 *5/*29,choice
576,cyp2d6-times-5-over-times-5,CYP2D6 *5/*5,choice
577,cyp2d6-times-6-over-times-35,CYP2D6 *6/*35,choice
578,cyp2d6-times-6-over-times-41,CYP2D6 *6/*41,choice
579,cyp2d6-times-6-over-times-6,CYP2D6 *6/*6,choice
580,cyp2d6-times-7-over-times-41,CYP2D6 *7/*41,choice
581,cyp2d6-times-other-over-times-17,CYP2D6 *other/*17,choice
582,cyp2d6-times-other-over-times-29,CYP2D6 *other/*29,choice
583,cyp2d6-times-other-over-times-41,CYP2D6 *other/*41,choice
584,cyp2d6-times-other-over-times-other,CYP2D6 *other/*other,choice
585,cyp2d6-times-x-over-times-4,CYP2D6 *x/*4,choice
586,cyp2d6-variant,gene variant,measurement_type
587,cyp2d6-variant-not-reported,Not reported cyp2d6 variant,choice
588,cyp2e1,CYP2E1,choice
589,cyp2e1-genotype,CYP2E1 genotype,measurement_type
590,cyp2e1-genotype-not-reported,Not reported cyp2e1 genotype,choice
591,cyp2e1-times-1a-over-times-1a,CYP2E1 *1A/*1A,choice
592,cyp2e1-times-1a-over-times-5,CYP2E1 *1A/*5,choice
593,cyp2e1-times-5-over-times-5,CYP2E1 *5/*5,choice
594,cyp3a4-genotype,CYP3A4 genotype,measurement_type
595,cyp3a4-genotype-not-reported,Not reported cyp3a4 genotype,choice
596,cyp3a4-other-over-times-1b,CYP3A4 other/*1B,choice
597,cyp3a4-times-1-over-times-1,CYP3A4 *1/*1,choice
598,cyp3a4-times-1-over-times-22,CYP3A4 *1/*22,choice
599,cyp3a4-wildtype-over-wildtype,CYP3A4 wildtype/wildtype,choice
600,cyp3a5-a-over-a,CYP3A5 A/A,choice
601,cyp3a5-a-over-g,CYP3A5 A/G,choice
602,cyp3a5-genotype,CYP3A5 genotype,measurement_type
603,cyp3a5-genotype-not-reported,Not reported cyp3a5 genotype,choice
604,cyp3a5-g-over-g,CYP3A5 G/G,choice
605,cyp3a5-other-over-times-1c,CYP3A5 other/*1C,choice
606,cyp3a5-other-over-times-3,CYP3A5 other/*3,choice
607,cyp3a5-times-1-over-times-1,CYP3A5 *1/*1,choice
608,cyp3a5-times-1-over-times-3,CYP3A5 *1/*3,choice
609,cyp3a5-times-3-over-times-1,CYP3A5 *3/*1,choice
610,cyp3a5-times-3-over-times-3,CYP3A5 *3/*3,choice
611,cystic-kidney-disease,cystic kidney disease,choice
612,czx6oh-plus-czxoglu,czx6oh+czxoglu,substance
613,czxoglu,chlorzoxazone O-glucuronide,substance
614,dapagliflozin,dapagliflozin,substance
615,dapagliflozin-2-o-glucuronide,dapagliflozin 2-o-glucuronide,substance
616,dapagliflozin-3-o-glucuronide,dapagliflozin 3-o-glucuronide,substance
617,daytime,daytime,choice
618,deb,debrisoquine,substance
619,deb-over-4hdeb,deb/4hdeb,substance
620,deb-sul,debrisoquine sulfate,substance
621,decompensated-liver-cirrhosis,decompensated liver cirrhosis,choice
622,demographics-measurement,demographics measurement,measurement_type
623,deoxyschizandrin,deoxyschizandrin,substance
624,desipramine,desipramine,substance
625,desmethyldiazepam-conjugated,desmethyldiazepam conjugated,substance
626,dextromethadone,dextromethadone,substance
627,dexverapamil,dexverapamil,substance
628,diabetes,diabetes,choice
629,diabetic-nephropathy,diabetic nephropathy,choice
630,diazepam,diazepam,substance
631,diclofenac,diclofenac,substance
632,diet,diet,measurement_type
633,dietary-supplement,dietary supplement,substance
634,diethyldithiocarbamic-acid,diethyldithiocarbamic acid,substance
635,diet-not-reported,Not reported diet,choice
636,diffuse-glomerulonephritis,diffuse glomerulonephritis,choice
637,diflunisal,diflunisal,substance
638,digitoxin,digitoxin,substance
639,digoxin,digoxin,substance
640,dihydrogen,dihydrogen (H2),substance
641,diltiazem,diltiazem,substance
642,dimethadione,dimethadione,substance
643,diosmin,diosmin,substance
644,disease,disease,measurement_type
645,disease-not-reported,Not reported disease,choice
646,disease-of-glucose-metabolism,disease of glucose metabolism,choice
647,disulfiram,disulfiram,substance
648,dmt,dextromethorphan,substance
649,dmthbr,dextromethorphan hydrobromide,substance
650,dmt-over-dtf,dextromethorphan/dextrorphan,substance
651,dmt-over-dtf-plus-dtfglu,(dmt)/(dtf+dtfglu),substance
652,dmt-over-dtf-plus-dtfglu-plus-hm3-plus-hm3glu,(dmt)/(dtf+dtfglu+hm3+hm3glu),substance
653,dmt-over-dtf-plus-hm3,dmt/(dtf+hm3),substance
654,dmt-over-hm3,dextromethorphan/3-hydroxymorphinan,substance
655,dmt-over-hm3-plus-hm3glu,dextromethorphan/3-hydroxymorphinan,substance
656,dmt-over-mom3,dextromethorphan/3-methoxymorphinan,substance
657,dob,delta over baseline (DOB),measurement_type
658,dosing,dosing,measurement_type
659,dosing-intervention,dosing intervention,measurement_type
660,dosing-substances-all,substances all,info_node
661,drug-induced-hepatitis,drug-induced hepatitis,choice
662,dtf,dextrorphan,substance
663,dtfglu,dextrorphan O-glucuronide,substance
664,dtf-over-dmt,dextrorphan/dextromethorphan,substance
665,dtf-over-hm3,dextrorphan/3-hydroxymorphinan,substance
666,dtf-over-mom3,dextrorphan/3-methoxymorphinan,substance
667,dtf-plus-dtfglu,dtf+dtfglu,substance
668,dtf-plus-dtfglu-over-dmt,(dtf+dtfglu)/(dmt),substance
669,dtf-plus-dtfglu-over-hm3-plus-hm3glu,total dextrorphan/ total 3-hydroxymorphinan,substance
670,dtf-plus-hm3-over-dmt-plus-mom3,(dtf+hm3)/(dmt+mom3),substance
671,duloxetine,duloxetine,substance
672,education-duration,education duration,measurement_type
673,education-measurement,education measurement,measurement_type
674,ee2,ethinylestradiol,substance
675,efavirenz,efavirenz,substance
676,egp,endogeneous glucose production (EGP),measurement_type
677,egp-substances-all,substances all,info_node
678,ehr,Exercise heart rate (EHR),measurement_type
679,ehr-change,Exercise heart rate change (EHR),measurement_type
680,ehr-change-auec,Area under the effect curve (AUEC) of EHR,measurement_type
681,ehr-change-average,Exercise heart rate change average (AUEC/tau),measurement_type
682,ehr-change-fluctuations,Exercise heart rate change fluctations,measurement_type
683,elder,elder,choice
684,elisa,enzyme-linked immunosorbent assay (ELISA),method
685,emit,Enzyme Multiplied Immunoassay Technique (EMIT),method
686,enalapril,enalapril,substance
687,enantiomeric-ratio,enantiomeric ratio,measurement_type
688,endocrine-system-disease,endocrine system disease,choice
689,enflurane,enflurane,substance
690,enoxacin,enoxacin,substance
691,enzymatic-assay,enzymatic assay,method
692,ephedrine,ephedrine,substance
693,epilepsy,epilepsy,choice
694,epinephrine,epinephrine,substance
695,ergotamine,ergotamine,substance
696,ermbt,Erythromycin breath test (ERMBT),measurement_type
697,erythromycin,erythromycin,substance
698,es-ms-ms,Positive electrospray ionisation tandem mass spectrometry (ES+ MS/MS),method
699,essential-amino-acids,Essential amino acids (EAA),substance
700,estradiol,estradiol,substance
701,estradiol-benzoate,estradiol benzoate,substance
702,ethanol,ethanol,substance
703,ethnicity,ethnicity,measurement_type
704,ethnicity-not-reported,Not reported ethnicity,choice
705,etomidate,etomidate,substance
706,etravirine,etravirine,substance
707,evans-blue,evans blue,substance
708,evening,evening,choice
709,excretion-rate,excretion rate,measurement_type
710,exenatide,exenatide,substance
711,exercise,exercise,measurement_type
712,exercise-categorial,exercise (categorial),measurement_type
713,exercise-categorial-not-reported,Not reported exercise (categorial),choice
714,exercise-no,No exercise,choice
715,exercise-not-reported,Not reported exercise,choice
716,exercise-yes,exercise,choice
717,exp3174,Losartan carboxylic acid (E3174),substance
718,extensive-intermediate-metabolizer,extensive/intermediate metabolizer (EM/IM),choice
719,extensive-metabolizer,extensive metabolizer (EM),choice
720,extensive-poor-metabolizer,extensive/poor metabolizer (EM/PM),choice
721,extraction-ratio,extraction ratio (ER),measurement_type
722,extrahepatic-portal-obstruction,extrahepatic portal obstruction,choice
723,ezetimibe,ezetimibe,substance
724,familial-hypercholesterolemia,familial hypercholesterolemia (FH),choice
725,family-history-diabetes,family history diabetes,measurement_type
726,family-history-diabetes-no,No family-history-diabetes,choice
727,family-history-diabetes-not-reported,Not reported family history diabetes,choice
728,family-history-diabetes-yes,family-history-diabetes,choice
729,family-history-disease,family history disease,measurement_type
730,family-history-disease-not-reported,Not reported family history disease,choice
731,fasting,fasting,measurement_type
732,fasting-duration,fasting (duration),measurement_type
733,fasting-no,No fasting,choice
734,fasting-not-reported,Not reported fasting,choice
735,fasting-status,fasting status,measurement_type
736,fasting-yes,fasting,choice
737,fat-free-mass-index,fat free mass index (FFMI),measurement_type
738,fatty-liver-disease,fatty liver disease,choice
739,fat-weight,fat mass (FM),measurement_type
740,feces,feces,tissue
741,feces-urine,feces_urine,tissue
742,feeding-ad-libitum,ad libitum,choice
743,feeding-protocol,feeding protocol,measurement_type
744,feeding-protocol-not-reported,Not reported feeding protocol,choice
745,feeding-time-restricted,time restricted,choice
746,female,female,choice
747,fenofibrate,fenofibrate,substance
748,fentanyl,fentanyl,substance
749,fexofenadine,fexofenadine,substance
750,ffa,free fatty acids (FFA),substance
751,flurbiprofen,flurbiprofen,substance
752,fluvastatin,fluvastatin,substance
753,fluvoxamine,fluvoxamine,substance
754,focal-glomerulonephritis,focal glomerulonephritis,choice
755,follicular-phase,follicular phase,choice
756,fpia,fluorescence polarization immunoassay (FPIA),method
757,fraction-absorbed,fraction absorbed,measurement_type
758,fraction-absorbed-substances-all,substances all,info_node
759,fractional-liver-remnant-volume,fractional liver remnant volume,measurement_type
760,fractional-pdr,fractional plasma disappearance rate (PDR),measurement_type
761,fraction-unbound,fraction unbound,measurement_type
762,fraction-unbound-substances-all,substances all,info_node
763,fructosamine,fructosamine,substance
764,furosemide,furosemide,substance
765,galactose,galactose,substance
766,garlic-oil,garlic oil,substance
767,gas-lc,Gas-liquid chromatography (GLC),method
768,gastric-juice-volume,gastric juice volume,measurement_type
769,gastric-measurement,gastric measurement,measurement_type
770,gc,Gas chromatography,method
771,gc-ms,Gas chromatography mass spectrometry (GC/MS),method
772,gemfibrozil,gemfibrozil,substance
773,gene-duplication,gene duplication,choice
774,gene-measurement,gene measurement,measurement_type
775,gene-phenotype,gene phenotype,measurement_type
776,gene-variant,gene variant,measurement_type
777,genistein,genistein,substance
778,genotype,genotype,measurement_type
779,geometric-mean,geometric mean,calculation_type
780,geometric-mean-not-reported,Not reported geometric mean,choice
781,gestodene,gestodene,substance
782,ggt,Gamma glutamate transaminase (GGT),substance
783,gilbert-syndrome,Gilbert syndrome,choice
784,ginkgo-biloba,ginkgo biloba,substance
785,gip,gastric inhibitory polypeptide (GIP),substance
786,glibenclamide,glibenclamide (glyburide),substance
787,glipizide,glipizide,substance
788,glomerulonephritis,glomerulonephritis,choice
789,glomular-filtration-rate,Glomular filtration rate,measurement_type
790,glp-1,glucagon-like peptide-1 (GLP-1),substance
791,glucagon,glucagon,substance
792,glucose,D-glucose,substance
793,glucose-index,Glucose index,measurement_type
794,glucose-metabolism-challenge,glucose metabolism challenge,measurement_type
795,glucose-metabolism-challenge-not-reported,Not reported glucose metabolism challenge,choice
796,glucose-oral-disposition-index,Glucose oral disposition index,measurement_type
797,glycerol,glycerol,substance
798,glycocholic-acid,glycocholic acid,substance
799,glycosylated-hemoglobin-measurement,HbA1c (glycosylated haemoglobin),measurement_type
800,glycyrrhizin,glycyrrhizin,substance
801,goldenseal-root-extract,goldenseal root extract,substance
802,got,"Glutamic oxaloacetic transaminase (GOT, SGOT)",substance
803,grapefruit,grapefruit,substance
804,grapefruit-juice,grapefruit juice,substance
805,green-tea,green tea,substance
806,growth-hormone,growth hormone,substance
807,guaifenesin,guaifenesin,substance
808,h2o,water,substance
809,habf,hepatic arterial blood flow (HABF),measurement_type
810,haemoglobin,haemoglobin,substance
811,halothane,halothane,substance
812,hba1c,glycosylated hemoglobin (HbA1c),substance
813,hbf,Hepatic blood flow,measurement_type
814,hcv,Hepatitis C virus (HCV),choice
815,hdl,hdl,substance
816,hdl2-c,hdl2-c,substance
817,hdl3-c,hdl3-c,substance
818,hdlc,HDL cholesterol,substance
819,hdl-triglyceride,hdl-triglyceride,substance
820,hdl-triglyeride,hdl triglyceride,substance
821,health-status,health status,measurement_type
822,healthy,healthy,measurement_type
823,healthy-no,No healthy,choice
824,healthy-not-reported,Not reported healthy,choice
825,healthy-yes,healthy,choice
826,heart,heart,tissue
827,heart-disease,heart disease,choice
828,heart-failure,heart failure,choice
829,heart-measurement,heart measurement,measurement_type
830,heart-rate,heart rate,measurement_type
831,height,height,measurement_type
832,hematocrit,hematocrit,measurement_type
833,hematopoietic-and-lymphoid-system-disorder,hematopoietic and lymphoid system disorder,measurement_type
834,hemochromatosis,hemochromatosis,choice
835,hemodialysis,hemodialysis,choice
836,heparin,heparin,substance
837,hepatectomy,hepatectomy,choice
838,hepatitis,hepatitis,choice
839,hepatitis-b,hepatitis B,choice
840,hepatocellular-carcinoma,hepatocellular carcinoma,choice
841,herbal-dietary-supplement,herbal dietary supplement,substance
842,heterozygous-familial-hypercholesterolemia,heterozygous familial hypercholesterolemia (FH),choice
843,hispanic,Hispanic,choice
844,hm3,3-hydroxymorphinan,substance
845,hm3glu,3-hydroxymorphinan O-glucuronide,substance
846,hm3-over-mom3,3-hydroxymorphinan/3-methoxymorphinan,substance
847,hm3-plus-hm3glu,hm3+hm3glu,substance
848,hm3-plus-hm3glu-over-mom3,3-hydroxymorphinan/3-methoxymorphinan,substance
849,hm3-plus-hm3glu-plus-dtf-plus-dtfglu-plus-dex-plus-mom3,hm3+hm3glu+dtf+dtfglu+dex+mom3,substance
850,homa-ir,HOMA-IR,measurement_type
851,homo-sapiens,Homo sapiens,choice
852,homozygous-familial-hypercholesterolemia,homozygous familial hypercholesterolemia (FH),choice
853,housing,housing,measurement_type
854,housing-acclimatization-time,housing acclimatization time,measurement_type
855,housing-group-size,housing group size,measurement_type
856,housing-humidity,housing humidity,measurement_type
857,housing-temperature,housing temperature,measurement_type
858,hplc,High-performance liquid chromatography (HPLC),method
859,hplc-esi-ms,HPLC-ESI-MS,method
860,hplc-esi-ms-over-ms,HPLC-ESI-MS/MS,method
861,hplc-ms-ms,High performance liquid chromatography-tandem mass spectrometry (HPLC MS/MS),method
862,hplc-ms-uv,HPLC/MS/UV,method
863,hplc-uv,HPLC/UV,method
864,hydrochlorothiazide,hydrochlorothiazide,substance
865,hydrogencarbonate,hydrogencarbonate,substance
866,hydroxybupropion,hydroxybupropion,substance
867,hydroxyitraconazole,hydroxyitraconazole,substance
868,hydroxyrepaglinide,hydroxy repaglinide,substance
869,hypercholesterolemia,hypercholesterolemia,choice
870,hyperinsulinemic-euglycemic-clamp,hyperinsulinemic euglycemic clamp,choice
871,hypertension,hypertension,choice
872,hyperthyroidism,hyperthyroidism,choice
873,hypoglycemic-clamp,hypoglycemic clamp,choice
874,hypothyroidism,hypothyroidism,choice
875,ibuprofen,ibuprofen,substance
876,icg,indocyanine green,substance
877,idlc,IDL cholesterol,substance
878,idrocilamide,idrocilamide,substance
879,imatinib,imatinib,substance
880,immunofluorescence,immunofluorescence,method
881,impaired-glucose-tolerance,impaired glucose tolerance (IGT),choice
882,indo-trinidadians,Indo-Trinidadians,choice
883,infectious-disorder,infectious disorder,choice
884,inhalation,inhalation,route
885,inr,international normalized ratio (INR),measurement_type
886,insulin,insulin,substance
887,insulinogenic-index,Insulinogenic index,measurement_type
888,insulin-over-glucose,Insulin/Glucose,substance
889,intermediate-buoyant-ldl,intermediate-buoyant-ldl,substance
890,intermediate-metabolizer,intermediate metabolizer (IM),choice
891,intermediate-poor-metabolizer,intermediate/poor metabolizer (IM/PM),choice
892,intervention,intervention,info_node
893,intestine,intestine,tissue
894,intraarterial,intraarterial,route
895,intradermal,intradermal,route
896,intraduodenal,intraduodenal,route
897,intramuscular,intramuscular,route
898,intraperitoneal-route,intraperitoneal route,route
899,intravascular-route,intravascular route,route
900,intravenous-glucose-tolerance-test-ivgtt,ivgtt,choice
901,ipratropium-bromide,ipratropium bromide,substance
902,irbesartan,irbesartan,substance
903,isavuconazole,isavuconazole,substance
904,ischemic-heart-disease,ischemic heart disease,choice
905,isoflurane,isoflurane,substance
906,isoglycemic-glucose-infusion,isoglycemic glucose infusion,choice
907,isoniazid,isoniazid,substance
908,isosorbide-dinitrate,isosorbide dinitrate,substance
909,isradipine,isradipine,substance
910,itraconazole,itraconazole,substance
911,iv,intravenous (iv),route
912,japanese,Japanese,choice
913,kabs,absorption rate (Kabs),measurement_type
914,kabs-substances-all,substances all,info_node
915,kava-kava-root-extract,kava kava root extract,substance
916,kel,elimination rate (Kel),measurement_type
917,kel-substances-all,substances all,info_node
918,ketoconazole,ketoconazole,substance
919,ketoitraconazole,ketoitraconazole,substance
920,key-lifestyle-measurement,key lifestyle measurement,measurement_type
921,kidney,kidney,tissue
922,kidney-function-test,kidney function test,measurement_type
923,kidney-function-test-not-reported,Not reported kidney function test,choice
924,kidney-weight,kidney weight,measurement_type
925,kola-nuts,kola nuts,substance
926,korean,Korean,choice
927,lacidipine,lacidipine,substance
928,lactate,L-lactate,substance
929,lag-absorption,lag time of absorption,measurement_type
930,large-buoyant-ldl,large-buoyant-ldl,substance
931,large-intestine,large intestine,tissue
932,l-ascorbic-acid,vitamin c,substance
933,lathosterol,lathosterol,substance
934,lc-ms,Liquid chromatography mass spectrometry (LC/MS),method
935,lc-ms-ms,Liquid chromatography-tandem mass spectrometry (LC MS/MS),method
936,lc-uv,LC/UV,method
937,l-cysteine,L-cysteine,substance
938,ldh,Lacate dehydrogenase (LDH),substance
939,ldl,ldl,substance
940,ldl1,ldl1,substance
941,ldl2,ldl2,substance
942,ldl3,ldl3,substance
943,ldl4,ldl4,substance
944,ldl5,ldl5,substance
945,ldl6,ldl6,substance
946,ldl7,ldl7,substance
947,ldl-apob100-plus-48,ldl-apoB100+48,substance
948,ldlc,LDL cholesterol,substance
949,ldl-esterified-over-free-cholesterol,ldl-esterified/free-cholesterol,substance
950,ldl-over-hdl-c,ldl/hdl-c,substance
951,ldl-triglyceride,ldl-triglyceride,substance
952,ldl-triglyeride,ldl triglyceride,substance
953,lean-body-mass,lean body mass (LBW),measurement_type
954,leukaemia,leukemia,choice
955,levomethadone,levomethadone,substance
956,levonorgestrel,levonorgestrel,substance
957,lidocaine,lidocaine,substance
958,lifestyle-measurement,lifestyle measurement,measurement_type
959,light-dark-cycle,light-dark-cycle,measurement_type
960,light-dark-cycle-0-24,light/dark 0/24,measurement_type
961,light-dark-cycle-0-24-not-reported,Not reported light/dark 0/24,choice
962,light-dark-cycle-12-12,light/dark 12/12,measurement_type
963,light-dark-cycle-12-12-not-reported,Not reported light/dark 12/12,choice
964,light-dark-cycle-16-8,light/dark 16/8,measurement_type
965,light-dark-cycle-16-8-not-reported,Not reported light/dark 16/8,choice
966,light-dark-cycle-24-0,light/dark 24/0,measurement_type
967,light-dark-cycle-24-0-not-reported,Not reported light/dark 24/0,choice
968,light-dark-cycle-not-reported,Not reported light-dark-cycle,choice
969,light-exercise,light exercise,choice
970,lipid-glucose-protein-challenge,lipid-glucose-protein challenge,choice
971,liver,liver,tissue
972,liver-cirrhosis,liver cirrhosis,choice
973,liver-damage,liver damage,choice
974,liver-disease,liver disease,choice
975,liver-disease-mild,liver disease (mild),choice
976,liver-disease-minimal,liver disease (minimal),choice
977,liver-disease-moderate,liver disease (moderate),choice
978,liver-disease-severe,liver disease (severe),choice
979,liver-fibrosis,liver fibrosis,choice
980,liver-fibrosis-f1,liver fibrosis (F1),choice
981,liver-fibrosis-f2,liver fibrosis (F2),choice
982,liver-fibrosis-f3,liver fibrosis (F3),choice
983,liver-fibrosis-f4,liver fibrosis (F4),choice
984,liver-function-test,liver function test,measurement_type
985,liver-function-test-not-reported,Not reported liver function test,choice
986,liver-homogenate,liver homogenate,tissue
987,liver-oedem,liver oedem,choice
988,liver-operation,liver operation,measurement_type
989,liver-operation-not-reported,Not reported liver operation,choice
990,liver-remnant-volume,liver remnant volume,measurement_type
991,liver-resection-rate,liver resection rate,measurement_type
992,liver-stasis,liver stasis,choice
993,liver-volume,liver volume,measurement_type
994,liver-weight,liver weight,measurement_type
995,lomefloxacin,lomefloxacin,substance
996,lorazepam,lorazepam,substance
997,lorazepam-glucuronide,lorazepam glucuronide,substance
998,losartan,losartan,substance
999,lova,lovastatin,substance
1000,lovaacid,lovastatin acid,substance
1001,lung-cancer,lung cancer,choice
1002,luteal-phase,luteal phase,choice
1003,m3g,morphine-3-glucuronide,substance
1004,m3g-plus-m6g,m3g+m6g,substance
1005,m6g,morphine-6-glucuronide,substance
1006,malaria,malaria,choice
1007,male,male,choice
1008,map,Mean arterial pressure (MAP),measurement_type
1009,marijuana,marijuana,measurement_type
1010,marijuana-amount-joints,marijuana amount (joints),measurement_type
1011,marijuana-duration,marijuana duration,measurement_type
1012,marijuana-no,No marijuana,choice
1013,marijuana-not-reported,Not reported marijuana,choice
1014,marijuana-status,marijuana status,measurement_type
1015,marijuana-yes,marijuana,choice
1016,mat,mean absorption time (MAT),measurement_type
1017,matsuda-index,Matsuda index,measurement_type
1018,maximum-excretion-rate,maximum excretion rate (ERmax),measurement_type
1019,mdma,"3,4-Methylenedioxymethamphetamine (MDMA)",substance
1020,meal,meal,measurement_type
1021,measurement,measurement,info_node
1022,medical-procedure,medical procedure,measurement_type
1023,medical-procedure-not-reported,Not reported medical procedure,choice
1024,medication,medication,measurement_type
1025,medication-amount,medication amount,measurement_type
1026,medication-amount-substances-all,substances all,info_node
1027,medication-duration,medication duration,measurement_type
1028,medication-duration-substances-all,substances all,info_node
1029,medication-no,No medication,choice
1030,medication-not-reported,Not reported medication,choice
1031,medication-status,medication status,measurement_type
1032,medication-substances-all,substances all,info_node
1033,medication-yes,medication,choice
1034,mefenamic-acid,mefenamic acid,substance
1035,melatonin,melatonin,substance
1036,melatonin6oh,6-hydroxymelatonin,substance
1037,memantine,memantine,substance
1038,menstrual-status,menstrual status,measurement_type
1039,menstrual-status-not-reported,Not reported menstrual status,choice
1040,menstrual-time-of-cycle,menstrual time of cycle,measurement_type
1041,mep,mephenytoin,substance
1042,meperidine,meperidine,substance
1043,metabolic-challenge,metabolic challenge,measurement_type
1044,metabolic-challenge-not-reported,Not reported metabolic challenge,choice
1045,metabolic-fraction,metabolic_fraction,measurement_type
1046,metabolic-measurement,metabolic measurement,measurement_type
1047,metabolic-phenotype,metabolic phenotype,measurement_type
1048,metabolic-phenotype-not-reported,Not reported metabolic phenotype,choice
1049,metabolic-phenotype-substances-all,substances all,info_node
1050,metabolic-ratio,metabolic ratio,measurement_type
1051,metabolic-ratio-substances-all,substances all,info_node
1052,metformin,metformin,substance
1053,methacetin,methacetin,substance
1054,methadone-hydrochloride,methadone hydrochloride,substance
1055,metoclopramide,metoclopramide,substance
1056,metoh-plus-mam,alpha-hydroxymetoprolol + metoprolol-acidic-metabolite,substance
1057,metoprolol,metoprolol,substance
1058,metoprolol-acidic-metabolite,metoprolol acidic metabolite,substance
1059,metoprolol-over-alpha-hydroxymetoprolol,metoprolol/alpha-hydroxymetoprolol,substance
1060,metoprolol-tartrate,metoprolol tartrate,substance
1061,met-plus-metoh-plus-mam,metoprolol + alpha-hydroxymetoprolol + metoprolol-acidic-metabolite,substance
1062,mexiletine,mexiletine,substance
1063,mibefradil,mibefradil,substance
1064,midazolam,midazolam,substance
1065,midazolam-hydrochloride,midazolam hydrochloride,substance
1066,migraine,migraine,choice
1067,miscellaneous-liver-disease,miscellaneous liver disease,choice
1068,mixed-hypercholesterolemia,mixed hypercholesterolemia,choice
1069,mixed-meal,mixed meal,choice
1070,mixed-sex,male and female,choice
1071,modafinil-sulfone,modafinil sulfone,substance
1072,moderate-exercise,moderate exercise,choice
1073,mom3,3-methoxymorphinan,substance
1074,mongrel-dog,Mongrel dog,choice
1075,mor,morphine,substance
1076,mor-h,morphine hydrochloride,substance
1077,morning,morning,choice
1078,mor-over-cod,morphine/codeine,substance
1079,mor-p,morphine phosphate,substance
1080,mor-plus-m3g-plus-m6g,mor+m3g+m6g,substance
1081,mor-plus-m3g-plus-m6g-over-cod-plus-c6g,(mor+m3g+m6g)/(cod+c6g),substance
1082,mor-plus-m3g-plus-m6g-plus-cod-plus-ncod-plus-c6g-plus-ncc,mor+m3g+m6g+cod+ncod+c6g+ncc,substance
1083,mor-plus-m3g-plus-m6g-plus-nmor-over-cod-plus-ncod-plus-c6g,(mor+m3g+m6g+nmor)/(cod+ncod+c6g),substance
1084,mor-plus-m3g-plus-m6g-plus-nmor-plus-cod-plus-ncod-plus-c6g-plus-ncg,mor+m3g+m6g+nmor+cod+ncod+c6g+ncg,substance
1085,mor-plus-ncod-plus-c6g,mor+ncod+c6g,substance
1086,mor-s,morphine sulfate,substance
1087,mouse-strain,mouse strain,measurement_type
1088,mouse-strain-c57bl,C57BL,measurement_type
1089,mouse-strain-c57bl6,C57BL6,measurement_type
1090,mouse-strain-c57bl6j,C57BL/6J,measurement_type
1091,mouse-strain-c57bl6j-not-reported,Not reported C57BL/6J,choice
1092,mouse-strain-c57bl6n,C57BL/6N,measurement_type
1093,mouse-strain-c57bl6n-not-reported,Not reported C57BL/6N,choice
1094,mouse-strain-c57bl6-not-reported,Not reported C57BL6,choice
1095,mouse-strain-c57bl-not-reported,Not reported C57BL,choice
1096,mouse-strain-not-reported,Not reported mouse strain,choice
1097,mp-em,Extensive metabolizer (EM),choice
1098,mp-im,Intermediate metabolizer (IM),choice
1099,mp-pm,Poor metabolizer (PM),choice
1100,mp-um,Ultra rapid metabolizer (UM),choice
1101,mrt,mean residence time (MRT),measurement_type
1102,mrt-substances-all,substances all,info_node
1103,ms,Mass Spectrometry (MS),method
1104,multiple-dose,multiple dose,application
1105,multiple-dosing-cmax,multiple dosing maximal concentration,measurement_type
1106,multiple-dosing-cmin,multiple dosing minimal concentration,measurement_type
1107,muscle,muscle,tissue
1108,muscle-weight,muscle weight,measurement_type
1109,mus-musculus,Mus musculus,choice
1110,mx,methylxanthine,substance
1111,myocardial-infarction,myocardial infarction,choice
1112,nafld,NAFLD,choice
1113,naloxone,naloxone,substance
1114,naringenin,naringenin,substance
1115,nash,NASH,choice
1116,nat2-activity,NAT2 activity,measurement_type
1117,nat2-activity-0,0,choice
1118,nat2-activity-1,1,choice
1119,nat2-activity-2,2,choice
1120,nat2-activity-not-reported,Not reported nat2 activity,choice
1121,nat2-phenotype,NAT2 phenotype,measurement_type
1122,nat2-phenotype-not-reported,Not reported nat2 phenotype,choice
1123,ncc,norcodeine-conjugates,substance
1124,ncg,norcodeine 6-glucuronide,substance
1125,ncod,norcodeine,substance
1126,n-desalkyl-itraconazole,n-desalkyl-itraconazole,substance
1127,n-desmethylclarithromycin,N-Desmethylclarithromycin,substance
1128,neaa,Non-essential amino acids (NEAA),substance
1129,nelfinavir,nelfinavir,substance
1130,neuronal-disease,neuronal disease,choice
1131,newborn,newborn,choice
1132,nicotine,nicotine,substance
1133,nifedipine,nifedipine,substance
1134,nighttime,nighttime,choice
1135,nighttime-pre-sleep,nighttime (pre-sleep),choice
1136,nizatidine,nizatidine,substance
1137,nmg,normorphine-glucuronide,substance
1138,nmor,normorphine,substance
1139,non-cirrhotic-liver-disease,non-cirrhotic liver disease,choice
1140,non-hdlc,non-HDL cholesterol,substance
1141,nordazepam,nordazepam,substance
1142,norepinephrine,norepinephrine,substance
1143,norfloxacin,norfloxacin,substance
1144,normal-weight,normal weight,choice
1145,norverapamil,norverapamil,substance
1146,nr-application,Not reported (application),application
1147,nr-form,Not reported (administration form),form
1148,nr-method,Not reported (method),method
1149,nr-route,Not reported (route),route
1150,nr-substance,Not reported (substance),substance
1151,nr-tissue,Not reported (tissue),tissue
1152,nsclc,Non small cell lung cancer (NSCLC),choice
1153,obese,obese,choice
1154,obesity-index,obesity index,measurement_type
1155,obeticholic-acid,obeticholic acid,substance
1156,oedem,oedem,choice
1157,ofloxacin,ofloxacin,substance
1158,omeprazole,omeprazole,substance
1159,omeprazole-metabolites,omeprazole metabolites,substance
1160,omeprazole-sulfone,omeprazole sulfone,substance
1161,oral,oral (po),route
1162,oral-contraceptives,oral contraceptives,measurement_type
1163,oral-contraceptives-duration,oral contraceptives duration,measurement_type
1164,oral-contraceptives-no,No oral-contraceptives,choice
1165,oral-contraceptives-not-reported,Not reported oral contraceptives,choice
1166,oral-contraceptive-status,oral contraceptive status,measurement_type
1167,oral-contraceptives-yes,oral-contraceptives,choice
1168,oral-glucose-tolerance-test-ogtt,ogtt,choice
1169,orange-juice,orange juice,substance
1170,organ-morphological-measurement,organ morphological measurement,measurement_type
1171,organ-volume,organ volume,measurement_type
1172,organ-weight,organ weight,measurement_type
1173,orlistat,orlistat,substance
1174,oro-cecal-transit-time,oro-cecal transit time,measurement_type
1175,oro-cecal-transit-time-substances-all,substances all,info_node
1176,osilodostrat,osilodostrat,substance
1177,osimertinib,osimertinib,substance
1178,overnight-fast,overnight fast,measurement_type
1179,overnight-fast-no,No overnight-fast,choice
1180,overnight-fast-not-reported,Not reported overnight fast,choice
1181,overnight-fast-yes,overnight-fast,choice
1182,overweight,overweight,choice
1183,ovulatory-phase,ovulatory phase,choice
1184,oxazepam,oxazepam,substance
1185,oxazepam-glucuronide,oxazepam glucuronide,substance
1186,oxaz-plus-oxazglu,oxazepam + oxazepam glucuronide,substance
1187,paclitaxel,paclitaxel,substance
1188,panadol-extend,panadol extend,substance
1189,panax-ginseng,panax ginseng,substance
1190,pancreas,pancreas,tissue
1191,pancreatic-disease,pancreatic disease,choice
1192,paroxetine,paroxetine,substance
1193,pbc,PBC,choice
1194,pbf,portal blood flow (PBF),measurement_type
1195,pdr,plasma disappearance rate (PDR),measurement_type
1196,pefloxacin,pefloxacin,substance
1197,pentagastrin,pentagastrin,substance
1198,pentazocine,pentazocine,substance
1199,pepsin,pepsin,substance
1200,percent-gastric-emptying,gastric emptying percentage,measurement_type
1201,pharmacokinetic-measurement,pharmacokinetic measurement,measurement_type
1202,phenacetin,phenacetin,substance
1203,phenobarbital,phenobarbital,substance
1204,phenobarbitone,phenobarbital,substance
1205,phenylalanine,phenylalanine,substance
1206,phenylbutazone,phenylbutazone,substance
1207,phenytoin,phenytoin,substance
1208,pholcodine,pholcodine,substance
1209,phosphate,phosphate,substance
1210,phospholipids,phospholipids,substance
1211,physiological-measurement,physiological measurement,measurement_type
1212,physiological-status,physiological status,measurement_type
1213,pioglitazone,pioglitazone,substance
1214,pipemidic-acid,pipemidic acid,substance
1215,piperine,piperine,substance
1216,pirenzepine,pirenzepine,substance
1217,pitavastatin,pitavastatin,substance
1218,placebo,placebo,substance
1219,plasma,plasma,tissue
1220,plasma-binding,plasma binding,measurement_type
1221,plasma-binding-measurement,plasma binding measurement,method
1222,plasma-binding-substances-all,substances all,info_node
1223,plasma-thromboplastin-activity,plasma thromboplastin activity,measurement_type
1224,poloxamer188,Poloxamer 188,substance
1225,pomegranate-juice,pomegranate-juice,substance
1226,poor-metabolizer,poor metabolizer (PM),choice
1227,postnecrotic-cirrhosis,postnecrotic cirrhosis,choice
1228,postpartum,postpartum,choice
1229,potassium,potassium,substance
1230,powder,powder,form
1231,pra,pravastatin,substance
1232,pra-plus-sq31906-plus-sq31945,pravastatin + SQ 31906 + SQ 31945,substance
1233,prealbumin-measurement,prealbumin measurement,measurement_type
1234,pregnancy-status,pregnancy status,measurement_type
1235,pregnant,pregnant,measurement_type
1236,pregnant-categorial,pregnant (categorial),measurement_type
1237,pregnant-categorial-not-reported,Not reported pregnant (categorial),choice
1238,pregnant-first-trimester,pregnant (first trimester),choice
1239,pregnant-no,No pregnant,choice
1240,pregnant-not-reported,Not reported pregnant,choice
1241,pregnant-second-trimester,pregnant (second trimester),choice
1242,pregnant-third-trimester,pregnant (third trimester),choice
1243,pregnant-yes,pregnant,choice
1244,premature-ventricular-contraction,premature ventricular contraction,choice
1245,primary-ventricular-fibrillation,primary ventricular fibrillation,choice
1246,primidone,primidone,substance
1247,probenecid,probenecid,substance
1248,probucol,probucol,substance
1249,progesterone,progesterone,substance
1250,proguanil,proguanil,substance
1251,proguanil-hydrochloride,proguanil hydrochloride,substance
1252,prone,prone,choice
1253,propacetamol,propacetamol,substance
1254,propanolol,propanolol,substance
1255,propantheline,propantheline,substance
1256,propatyl-nitrate,propatyl nitrate,substance
1257,propiverine,propiverine,substance
1258,propofol,propofol,substance
1259,protein-metabolic-challenge,protein metabolic challenge,choice
1260,protein-solution,protein solution,choice
1261,prothrombin-time,prothrombin time,measurement_type
1262,prothrombin-time-ratio,prothrombin time ratio,measurement_type
1263,pseudoephedrine,pseudoephedrine,substance
1264,psychatric-disorder,psychatric disorder,choice
1265,ptf,percentage of peak-trough fluctuations (PTF),measurement_type
1266,px,paraxanthine (17X),substance
1267,px-over-caf,paraxanthine/caffeine,substance
1268,px-over-tp,paraxanthine/theophylline,substance
1269,pyelonephritis,pyelonephritis,choice
1270,qualitative-dosing,qualitative dosing,measurement_type
1271,qualitative-dosing-substances-all,substances all,info_node
1272,quercetin,quercetin,substance
1273,qui,quinidine,substance
1274,quicki,QUICKI,measurement_type
1275,quinolone,quinolone,substance
1276,qui-s,quinidine sulphate,substance
1277,ra,Rate of appearance (Ra),measurement_type
1278,radioenzymatic-assay,radioenzymatic assay,method
1279,raltegravir,raltegravir,substance
1280,ranitidine,ranitidine,substance
1281,ra-substances-all,substances all,info_node
1282,rate,rate,measurement_type
1283,rate-cycling,Rate of cycling,measurement_type
1284,rate-gastric-emptying,gastric emptying rate,measurement_type
1285,rat-strain,rat strain,measurement_type
1286,rat-strain-not-reported,Not reported rat strain,choice
1287,rattus-norvegicus,Rattus norvegicus,choice
1288,rd,Rate of disappearance (Rd),measurement_type
1289,rd-substances-all,substances all,info_node
1290,recovery,recovery,measurement_type
1291,recovery-rate,recovery rate,measurement_type
1292,recovery-substances-all,substances all,info_node
1293,rectal,rectal,route
1294,recumbent-position,recumbent position,choice
1295,relative-peak-area,relative-peak-area,measurement_type
1296,renal-disease,renal disease,choice
1297,renal-disease-end-stage,renal disease (end-stage),choice
1298,renal-disease-mild,renal disease (mild),choice
1299,renal-disease-moderate,renal disease (moderate),choice
1300,renal-measurement,renal measurement,measurement_type
1301,repaglinide,repaglinide,substance
1302,rest,rest,choice
1303,restricted-dosing,restricted dosing,measurement_type
1304,resveratrol,resveratrol,substance
1305,retention-ratio,retention ratio,measurement_type
1306,ria,radioimmunoassay (RIA),method
1307,rifampicin,rifampicin,substance
1308,rifaximin,rifaximin,substance
1309,ritonavir,ritonavir,substance
1310,r-metoprolol,(-)-(R)-metoprolol,substance
1311,r-metoprolol-acidic-metabolite,(R)-metoprolol acidic metabolite,substance
1312,r-metoprolol-acidic-metabolite-over-r-metoprolol,(R)-metoprolol acidic metabolite/(R)-metoprolol,substance
1313,root,root,info_node
1314,rosuvastatin,rosuvastatin,substance
1315,rp-hplc,Reversed-phase high-performance liquid chromatography (RP-HPLC),method
1316,rtalinolol,R-talinolol,substance
1317,r-warfarin,r-warfarin,substance
1318,salbutamol,salbutamol,substance
1319,salicylamide,salicylamide,substance
1320,salicylamide-glucuronide,salicylamide glucuronide,substance
1321,salicylamide-sulfate,salicylamide sulfate,substance
1322,salicylic-acid,salicylic acid,substance
1323,salicyluric-acid,salicyluric acid,substance
1324,saliva,saliva,tissue
1325,saliva-over-plasma,saliva/plasma,tissue
1326,sample-mean,sample mean,calculation_type
1327,sample-mean-not-reported,Not reported sample mean,choice
1328,schizandra-chinensis,schizandra chinensis,substance
1329,schizophrenia,schizophrenia,choice
1330,scintillation-counting,scintillation counting,method
1331,secretion-rate,secretion rate,measurement_type
1332,secretion-rate-substances-all,substances all,info_node
1333,serum,serum,tissue
1334,setipiprant,setipiprant,substance
1335,sex,sex,measurement_type
1336,sex-not-reported,Not reported sex,choice
1337,shock,shock,choice
1338,shock-liver,shock liver,choice
1339,sickle-cell-disease,sickle cell disease,choice
1340,silexan,Lavender essential oil (Silexan),substance
1341,silymarin,silymarin,substance
1342,simva-plus-simacid,simvastatin + simvastatin acid,substance
1343,simvastatin,simvastatin,substance
1344,simvastatin-acid,simvastatin acid,substance
1345,single-component-meal,single component meal,choice
1346,single-dose,single dose,application
1347,sitosterol,sitosterol,substance
1348,sitting,sitting,choice
1349,slco1b1-c-388-a-over-a,SLCO1B1 c.388 A/A,choice
1350,slco1b1-c-388-a-over-g,SLCO1B1 c.388 A/G,choice
1351,slco1b1-c-388-g-over-g,SLCO1B1 c.388 G/G,choice
1352,slco1b1-c-521-c-over-c,SLCO1B1 c.521 C/C,choice
1353,slco1b1-c-521-t-over-c,SLCO1B1 c.521 T/C,choice
1354,slco1b1-c-521-t-over-t,SLCO1B1 c.521 T/T,choice
1355,slco1b1-c-571-c-over-c,SLCO1B1 c.571 C/C,choice
1356,slco1b1-c-571-c-over-t,SLCO1B1 c.571 C/T,choice
1357,slco1b1-c-571-t-over-t,SLCO1B1 c.571 T/T,choice
1358,slco1b1-c-597-c-over-c,SLCO1B1 c.597 C/C,choice
1359,slco1b1-c-597-c-over-t,SLCO1B1 c.597 C/T,choice
1360,slco1b1-c-597-t-over-t,SLCO1B1 c.597 T/T,choice
1361,slco1b1-g-11187-a-over-g,SLCO1B1 g.11187 A/G,choice
1362,slco1b1-g-11187-g-over-a,SLCO1B1 g.11187 G/A,choice
1363,slco1b1-g-11187-g-over-g,SLCO1B1 g.11187 G/G,choice
1364,slco1b1-genotype,SLCO1B1 genotype,measurement_type
1365,slco1b1-genotype-not-reported,Not reported SLCO1B1 genotype,choice
1366,slco1b1-no-times-15b,SLCO1B1 no *15b,choice
1367,slco1b1-no-times-17,SLCO1B1 no *17,choice
1368,slco1b1-times-15-over-times-15,SLCO1B1 *15/*15,choice
1369,slco1b1-times-1a-over-times-15,SLCO1B1 *1a/*15,choice
1370,slco1b1-times-1a-over-times-1a,SLCO1B1 *1a/*1a,choice
1371,slco1b1-times-1a-over-times-1b,SLCO1B1 *1a/*1b,choice
1372,slco1b1-times-1a-over-times-5,SLCO1B1 *1a/*5,choice
1373,slco1b1-times-1b-over-times-15,SLCO1B1 *1b/*15,choice
1374,slco1b1-times-1b-over-times-16,SLCO1B1 *1b/*16,choice
1375,slco1b1-times-1b-over-times-1b,SLCO1B1 *1b/*1b,choice
1376,slco1b1-times-1b-over-times-5,SLCO1B1 *1b/*5,choice
1377,slco1b1-times-1-over-times-1,SLCO1B1 *1/*1,choice
1378,slco1b1-times-1-over-times-16,SLCO1B1 *1/*16,choice
1379,slco1b1-times-x-over-times-15b,SLCO1B1 *x/*15b,choice
1380,slco1b1-times-x-over-times-17,SLCO1B1 *x/*17,choice
1381,sleeping-status,sleeping status,measurement_type
1382,sleeping-status-not-reported,Not reported sleeping status,choice
1383,small-buoyant-ldl,small-buoyant-ldl,substance
1384,small-intestine,small intestine,tissue
1385,s-metoprolol,(-)-(S)-metoprolol,substance
1386,s-metoprolol-acidic-metabolite,(S)-metoprolol acidic metabolite,substance
1387,s-metoprolol-acidic-metabolite-over-s-metoprolol,(S)-metoprolol acidic metabolite/(S)-metoprolol,substance
1388,s-metoprolol-over-r-metoprolol,(S)-metoprolol/(R)-metoprolol,substance
1389,smoking,smoking,measurement_type
1390,smoking-amount-cigarettes,smoking amount (cigarettes),measurement_type
1391,smoking-amount-packyears,smoking amount (packyears),measurement_type
1392,smoking-duration,smoking duration,measurement_type
1393,smoking-no,No smoking,choice
1394,smoking-not-reported,Not reported smoking,choice
1395,smoking-status,smoking status,measurement_type
1396,smoking-yes,smoking,choice
1397,sodium,sodium,substance
1398,sodium-hydrogencarbonate,sodium hydrogencarbonate,substance
1399,sodium-tanshinone-2a-sulfonate,Sodium tanshinone II A sulfonate,substance
1400,sodium-valproate,sodium valproate,substance
1401,solution,solution,form
1402,somatostatin,somatostatin,substance
1403,sorbitol,sorbitol,substance
1404,spar-over-2hspar-plus-5hspar,sparteine/(2hspar+5hspar),substance
1405,spar-plus-2hspar-plus-5hspar,sparteine + 2hspar + 5hspar,substance
1406,sparteine,sparteine,substance
1407,sparteine-sulfate,sparteine sulfate,substance
1408,species,species,measurement_type
1409,species-not-reported,Not reported species,choice
1410,spectrophotometry,spectrophotometry,method
1411,spinal-anaesthesia,spinal anaesthesia,choice
1412,spinal-fluid,spinal fluid,tissue
1413,spironolactone,spironolactone,substance
1414,sq31906,SQ 31906 (3'alpha-isopravastatin),substance
1415,sq31945,SQ 31945,substance
1416,stalinolol,S-talinolol,substance
1417,stasis,stasis,choice
1418,stigmasterol,stigmasterol,substance
1419,st-johns-wort-extract,St. John's wort extract,substance
1420,stomach,stomach,tissue
1421,strain,strain,measurement_type
1422,strain-not-reported,Not reported strain,choice
1423,stroke,stroke,choice
1424,subacute-hepatic-necrosis,subacute hepatic necrosis,choice
1425,subcutaneous,subcutaneous,route
1426,sublingual,sublingual,route
1427,succinylcholine,succinylcholine,substance
1428,sufentanil,sufentanil,substance
1429,sulfamethizole,sulfamethizole,substance
1430,sulfamethizole-acetylated,sulfamethizole acetylated,substance
1431,sulfapyridine,sulfapyridine,substance
1432,sulfasalazine,sulfasalazine,substance
1433,sulfinpyrazone,sulfinpyrazone,substance
1434,sunitinib,sunitinib,substance
1435,supine,supine,choice
1436,suppository,suppository,form
1437,s-warfarin,s-warfarin,substance
1438,swine,Swine,choice
1439,syrup,syrup,form
1440,tablet,tablet,form
1441,talinolol,talinolol,substance
1442,talinolol2cisoh,2-cis hydroxytalinolol,substance
1443,talinolol2oh,2-hydroxytalinolol,substance
1444,talinolol3cisoh,3-cis hydroxytalinolol,substance
1445,talinolol3transoh,3-trans hydroxytalinolol,substance
1446,talinolol4cisoh,4-cis hydroxytalinolol,substance
1447,talinolol4transoh,4-trans hydroxytalinolol,substance
1448,talinolol4transoh-plus-talinolol3cisoh-plus-talinolol2cisoh,4-trans hydroxytalinolol + 3-cis hydroxytalinolol + 2-cis hydroxytalinolol,substance
1449,talinolol4transoh-plus-talinolol3transoh-plus-talinolol3cisoh,4-trans hydroxytalinolol + 3-trans hydroxytalinolol + 3-cis hydroxytalinolol,substance
1450,talinolol4transoh-plus-talinolol4cisoh-plus-talinolol3transoh-plus-talinolol3cisoh-plus-talinolol2cisoh,4-trans hydroxytalinolol + 4-cis hydroxytalinolol + 3-trans hydroxytalinolol + 3-cis hydroxytalinolol + 2-cis hydroxytalinolol,substance
1451,tb,theobromine (37X),substance
1452,tb-over-caf,theobromine/caffeine,substance
1453,tea,tea,substance
1454,temazepam,temazepam,substance
1455,temazepam-glucuronide,temazepam glucuronide,substance
1456,temocapril,temocapril,substance
1457,temocaprilat,temocaprilat,substance
1458,terbinafine,terbinafine,substance
1459,tetrachloromethane,tetrachloromethane,substance
1460,thai,Thai,choice
1461,thalf,elimination half-life,measurement_type
1462,thalf-absorption,absorption half-life,measurement_type
1463,thalf-absorption-substances-all,substances all,info_node
1464,thalf-gastric-emptying,gastric emptying half-life,measurement_type
1465,thalf-substances-all,substances all,info_node
1466,thc,THC,substance
1467,theacrine,theacrine,substance
1468,thiabendazole,thiabendazole,substance
1469,thyroid-disease,thyroid disease,choice
1470,tipranavir,tipranavir,substance
1471,tissue,tissue,tissue
1472,tizanidine,tizanidine,substance
1473,tmax,time to maximum (Tmax),measurement_type
1474,tmax-substances-all,substances all,info_node
1475,tolbutamide,tolbutamide,substance
1476,torasemide,torasemide,substance
1477,torasemide-m1,torasemide-M1,substance
1478,torasemide-m3,torasemide-M3,substance
1479,torasemide-m5,torasemide-M5,substance
1480,total-amino-acids,Total amino acids (TAA),substance
1481,total-atorva-inhibitors,Total HMG-CoA reductase inhibitors (atorvastatin),substance
1482,total-lova-inhibitors,Total HMG-CoA reductase inhibitors (lovastatin),substance
1483,total-over-hdl-c,total/hdl-c,substance
1484,total-pra-inhibitors,Total HMG-CoA reductase inhibitors (pravastatin),substance
1485,total-simva,total simvastatin metabolites,substance
1486,total-simva-inhibitors,Total HMG-CoA reductase inhibitors (simvastatin),substance
1487,tp,theophylline (13X),substance
1488,tpgs,D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS),substance
1489,tp-over-caf,theophylline/caffeine,substance
1490,tp-plus-tb-plus-px-plus-1x-plus-3x-plus-7x-plus-1u-plus-7u-plus-13u-plus-17u-plus-137u-plus-caf,tp+tb+px+1X+3X+7X+1U+7U+13U+17U+137U+caf,substance
1491,tp-plus-tb-plus-px-plus-caf,tp+tb+px+caf,substance
1492,transluminal,transluminal,route
1493,triazolam,triazolam,substance
1494,triglyceride,triglyceride,substance
1495,trimethadione,trimethadione,substance
1496,troglitazone,troglitazone,substance
1497,troleandomycin,troleandomycin,substance
1498,tubal-ligation,tubal ligation (TL),choice
1499,type-1-diabetes-mellitus,type 1 diabetes mellitus (T1DM),choice
1500,type-2-diabetes-mellitus,type 2 diabetes mellitus (T2DM),choice
1501,u-13c-glucose,[U-13C]glucose,substance
1502,ultra-filtration,ultra-filtration,method
1503,ultra-rapid-metabolizer,ultra rapid metabolizer (UM),choice
1504,underweight,underweight,choice
1505,urea,urea,substance
1506,uric-acid,uric acid,substance
1507,urinary-volume,urinary volume,measurement_type
1508,urinary-volume-rate,urinary volume rate,measurement_type
1509,urine,urine,tissue
1510,uv-spectrophotometry,UV spectrophotometry,method
1511,valerian-root-extract,valerian root extract,substance
1512,valsartan,valsartan,substance
1513,vancomycin,vancomycin,substance
1514,variable-infusion,variable infusion,application
1515,vd,volume of distribution,measurement_type
1516,vd-ss,volume of distribution steady state,measurement_type
1517,vd-substances-all,substances all,info_node
1518,vd-unbound,volume of distribution unbound,measurement_type
1519,vd-unbound-substances-all,substances all,info_node
1520,vecuronium-bromide,vecuronium bromide,substance
1521,vegetarian,vegetarian,choice
1522,venlafaxine,venlafaxine,substance
1523,ventricular-fibrillation,ventricular fibrillation,choice
1524,verapamil,verapamil,substance
1525,viral-hepatitis,viral hepatitis,choice
1526,vitamin-k,vitamin K,substance
1527,vldl,vldl,substance
1528,vldl-apob100-plus-48,vldl-apoB100+48,substance
1529,vldlc,VLDL cholesterol,substance
1530,vldlc-over-triglyeride,vldl-c/triglyceride,substance
1531,vldl-triglyceride,vldl-triglyceride,substance
1532,vldl-triglyeride,vldl triglyceride,substance
1533,voriconazole,voriconazole,substance
1534,waist-circumference,waist circumference,measurement_type
1535,waist-to-hip-ratio,waist to hip ratio,measurement_type
1536,warfarin,warfarin,substance
1537,watercress,watercress,substance
1538,weight,weight,measurement_type
1539,weight-categorial,weight (categorial),measurement_type
1540,weight-categorial-not-reported,Not reported weight (categorial),choice
1541,weight-status,weight status,measurement_type
1542,western-blot,western blot,measurement_type
1543,western-blot-not-reported,Not reported western blot,choice
1544,white-new-zealanders,White New Zealanders,choice
1545,wildtype-gene,wildtype gene,choice
1546,work-fulltime,work fulltime,choice
1547,work-hours-categorial,work hours (categorial),measurement_type
1548,work-hours-categorial-not-reported,Not reported work hours (categorial),choice
1549,work-measurement,work measurement,measurement_type
1550,work-no-fulltime,work no fulltime,choice
1551,work-notime,work notime,choice
1552,work-parttime,work parttime,choice
1553,xanthine,xanthine,substance
1554,young,young,choice
1555,zolpidem,zolpidem,substance
